Evaluation of the activity of bispirazoles against recombinant Trypanosoma cruzi strains expressing ß-galactosidase
Background: Nifurtimox and benznidazole are the only drugs currently approved to treat Chagas disease, caused Trypanosoma cruzi. However, they display unsatisfactory efficacy and induce undesirable side effects. Therefore, identifying new compounds with specific activity against T. cruzi is of great...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | article |
| Vydáno: |
2023
|
| Témata: | |
| On-line přístup: | https://repositorio.puce.edu.ec/handle/123456789/43351 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Přidat tag